NEWS

Informatics initiative for global pharma company

Global pharmaceutical company UCB has launched a major new informatics initiative that will make use of Genedata’s Expressionist and Phylosopher platforms. The software will be used to help discover drugs for central nervous system disorders, allergies and respiratory diseases, immune disorders and oncology.

The Expressionist platform is ideal for biomarker discovery, and provides a single interface for scientists to access public and private data. Used in conjunction with Phylosopher, it will optimise the analysis and storage of UCB’s microarray data, providing even deeper insights into the biology of the systems being studied.

Dr Phil Scordis, UCB senior group leader for informatics explained: ‘Phylosopher will enable us to integrate proprietary data with relevant information from the public domain, and aid the interpretation of our experimental data.’

Genedata’s products were also chosen because they could be integrated with UCB’s existing databases and client servers.

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers